![Conrad Savoy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Conrad Savoy
Profile
Conrad Savoy served as President & Chief Executive Officer at Biopartners GmbH and Global Regulatory Affairs Leader at Hoffmann-La Roche, Inc. He holds an MBA from The Open University and a doctorate from the University of Basel.
Former positions of Conrad Savoy
Companies | Position | End |
---|---|---|
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | General Counsel | - |
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Chief Executive Officer | - |
Training of Conrad Savoy
The Open University | Masters Business Admin |
University of Basel | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- Conrad Savoy